We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Ecolab Stock Worth Buying as Growth Rises but Debt Risk Builds?
Read MoreHide Full Article
Key Takeaways
Ecolab's High-Tech, Digital and Life Sciences businesses posted double-digit second-quarter growth.
ECL expects 6%-7% second-half organic sales growth, with pricing and productivity supporting margins.
Ecolab's debt climbed to $13.18B, increasing financing risk as acquisition costs weigh on earnings.
Ecolab Inc. (ECL - Free Report) is delivering faster growth across High-Tech, Digital and Life Sciences while pricing and productivity support profitability. The question for investors is whether those improving fundamentals can outweigh substantially higher debt, acquisition-related costs and persistent macroeconomic risks.
The operating picture is improving, but the balance-sheet trade-off has become harder to ignore. That keeps the buy-or-wait decision dependent on sustained growth, margin execution and the financial impact of recent acquisitions.
Ecolab's Growth Engines Keep Expanding
Global High-Tech organic sales rose 29% in the second quarter of 2026, while Ecolab Digital sales increased 27%. Global Life Sciences organic sales advanced 15%, led by bioprocessing, pharmaceuticals and personal care.
These businesses broaden Ecolab’s growth mix beyond slower industrial operations. High-Tech is benefiting from semiconductor and data-center demand, while Digital and Life Sciences add software, connected solutions and regulated-production exposure to the company’s portfolio.
Image Source: Zacks Investment Research
ECL's Pricing and Productivity Support Margins
Second-quarter organic sales increased 5%, supported by 4% pricing and 1% volume growth. The volume gain came despite an approximately 1 percentage-point headwind from Middle East customer disruptions, while higher pricing helped offset rising commodity costs.
Organic operating income margin expanded 40 basis points to 18.8%. Management expects pricing to strengthen to 5%-6% in the second half and targets an organic operating income margin of about 20%, supported by productivity and cost savings.
Ecolab's Debt Load Complicates the Bull Case
Total debt reached $13.18 billion at the end of the second quarter, up from $8.49 billion at the end of the first quarter as Ecolab raised financing for recent acquisitions, including CoolIT Systems.
Net interest expense increased to $73.1 million from $63.2 million a year earlier. The higher financing burden, together with acquisition-related non-cash amortization, creates a near-term earnings offset even as CoolIT expands Ecolab’s data-center opportunity.
ECL Still Faces Macro and Competitive Pressure
Heavy Water organic sales declined 1% in the second quarter as softer basic-industry demand and weaker Middle East activity weighed on results. Energy volatility and geopolitical disruption could also pressure volumes or delay margin recovery if costs rise faster than pricing actions.
Competition adds another constraint. Pentair plc (PNR - Free Report) operates across residential, commercial and industrial water solutions, overlapping with parts of Ecolab’s water-management exposure. The Clorox Company (CLX - Free Report) also competes in health and hygiene markets, where its portfolio now includes Clorox Professional and Purell.
Price-sensitive customers may resist repeated increases, making value-based pricing harder to sustain if lower-cost alternatives gain traction. That risk matters because Ecolab’s margin outlook assumes pricing and productivity will continue to offset inflation.
Image Source: Zacks Investment Research
Ecolab's Earnings Outlook Offers Near-Term Support
Ecolab raised its 2026 adjusted earnings guidance to $8.05-$8.25 per share from $8.03-$8.23, implying growth of 7%-10%. Management also expects second-half organic sales growth of 6%-7%.
Accelerating pricing, productivity and share gains support that outlook. Still, the guidance includes short-term non-cash amortization and financing costs related to CoolIT, so stronger operating performance must absorb part of the acquisition burden.
ECL's Underperform Signal Keeps the Bar High
Ecolab’s faster growth and improving margins strengthen the operating case, but higher leverage leaves less room for execution setbacks. The company must sustain growth while integrating acquisitions, protecting margins and managing a heavier financing load.
ECL currently carries a Zacks Rank #4 (Sell). Its Momentum Score of A is favorable, but the Value Score of F, Growth Score of C and VGM Score of D present a more cautious overall Style Score profile.
Zacks Style Scores are designed to complement the Zacks Rank rather than override it. The strong Momentum Score points to favorable price-trend characteristics, but the weaker Value and VGM readings, combined with the Zacks Rank #4, keep the near-term setup cautious.
For investors weighing whether to buy now or wait, the current signals favor patience rather than treating the company’s improving growth alone as sufficient reason to enter.
View the Zacks #1 Rank List
Image: Bigstock
Is Ecolab Stock Worth Buying as Growth Rises but Debt Risk Builds?
Key Takeaways
Ecolab Inc. (ECL - Free Report) is delivering faster growth across High-Tech, Digital and Life Sciences while pricing and productivity support profitability. The question for investors is whether those improving fundamentals can outweigh substantially higher debt, acquisition-related costs and persistent macroeconomic risks.
The operating picture is improving, but the balance-sheet trade-off has become harder to ignore. That keeps the buy-or-wait decision dependent on sustained growth, margin execution and the financial impact of recent acquisitions.
Ecolab's Growth Engines Keep Expanding
Global High-Tech organic sales rose 29% in the second quarter of 2026, while Ecolab Digital sales increased 27%. Global Life Sciences organic sales advanced 15%, led by bioprocessing, pharmaceuticals and personal care.
These businesses broaden Ecolab’s growth mix beyond slower industrial operations. High-Tech is benefiting from semiconductor and data-center demand, while Digital and Life Sciences add software, connected solutions and regulated-production exposure to the company’s portfolio.
Image Source: Zacks Investment Research
ECL's Pricing and Productivity Support Margins
Second-quarter organic sales increased 5%, supported by 4% pricing and 1% volume growth. The volume gain came despite an approximately 1 percentage-point headwind from Middle East customer disruptions, while higher pricing helped offset rising commodity costs.
Organic operating income margin expanded 40 basis points to 18.8%. Management expects pricing to strengthen to 5%-6% in the second half and targets an organic operating income margin of about 20%, supported by productivity and cost savings.
Ecolab's Debt Load Complicates the Bull Case
Total debt reached $13.18 billion at the end of the second quarter, up from $8.49 billion at the end of the first quarter as Ecolab raised financing for recent acquisitions, including CoolIT Systems.
Net interest expense increased to $73.1 million from $63.2 million a year earlier. The higher financing burden, together with acquisition-related non-cash amortization, creates a near-term earnings offset even as CoolIT expands Ecolab’s data-center opportunity.
ECL Still Faces Macro and Competitive Pressure
Heavy Water organic sales declined 1% in the second quarter as softer basic-industry demand and weaker Middle East activity weighed on results. Energy volatility and geopolitical disruption could also pressure volumes or delay margin recovery if costs rise faster than pricing actions.
Competition adds another constraint. Pentair plc (PNR - Free Report) operates across residential, commercial and industrial water solutions, overlapping with parts of Ecolab’s water-management exposure. The Clorox Company (CLX - Free Report) also competes in health and hygiene markets, where its portfolio now includes Clorox Professional and Purell.
Price-sensitive customers may resist repeated increases, making value-based pricing harder to sustain if lower-cost alternatives gain traction. That risk matters because Ecolab’s margin outlook assumes pricing and productivity will continue to offset inflation.
Image Source: Zacks Investment Research
Ecolab's Earnings Outlook Offers Near-Term Support
Ecolab raised its 2026 adjusted earnings guidance to $8.05-$8.25 per share from $8.03-$8.23, implying growth of 7%-10%. Management also expects second-half organic sales growth of 6%-7%.
Accelerating pricing, productivity and share gains support that outlook. Still, the guidance includes short-term non-cash amortization and financing costs related to CoolIT, so stronger operating performance must absorb part of the acquisition burden.
ECL's Underperform Signal Keeps the Bar High
Ecolab’s faster growth and improving margins strengthen the operating case, but higher leverage leaves less room for execution setbacks. The company must sustain growth while integrating acquisitions, protecting margins and managing a heavier financing load.
ECL currently carries a Zacks Rank #4 (Sell). Its Momentum Score of A is favorable, but the Value Score of F, Growth Score of C and VGM Score of D present a more cautious overall Style Score profile.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Style Scores are designed to complement the Zacks Rank rather than override it. The strong Momentum Score points to favorable price-trend characteristics, but the weaker Value and VGM readings, combined with the Zacks Rank #4, keep the near-term setup cautious.
For investors weighing whether to buy now or wait, the current signals favor patience rather than treating the company’s improving growth alone as sufficient reason to enter.